Arabic Arabic English English French French German German
dark

Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping TechnologyAlliance to expand the range of therapeutic and vaccine applications for the BioXp™ system

Codex DNA, Inc. today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanCap® technology. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Digital Health Funding Is Higher Than Ever Before

Next Post

Lexaria’s DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3

Related Posts
Total
0
Share